These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6255901)

  • 1. Cytotoxic antibody in cattle and sheep exposed to bovine leukemia virus.
    Honma T; Onuma M; Suneya M; Mikami T; Izawa H
    Arch Virol; 1980; 66(4):293-9. PubMed ID: 6255901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of complement-dependent lytic antibodies in sera from bovine leukemia virus-infected animals.
    Portetelle D; Bruck C; Burny A; Dekegel D; Mammerickx M; Urbain J
    Ann Rech Vet; 1978; 9(4):667-74. PubMed ID: 224763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antibody activity to bovine leukemia virus by complement.
    Watarai S; Onuma M; Mikami T; Izawa H
    Arch Virol; 1981; 68(2):135-42. PubMed ID: 6264895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against bovine leukosis virus infection in sheep with the BL 20 bovine lymphoblastoid cell line.
    Roberts DH; Lucas MH; Sands J; Wibberley G
    Vet Immunol Immunopathol; 1982 Nov; 3(6):635-42. PubMed ID: 6294966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein immunoblot test for detection of bovine leukemia virus p24 antibody in cattle and experimentally infected sheep.
    Walker PJ; Molloy JB; Rodwell BJ
    J Virol Methods; 1987 Feb; 15(3):201-11. PubMed ID: 3031113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV.
    Parfanovich MI; Zhdanov VM; Lazarenko AA; Nömm EM; Simovart YuA ; Parakin VK; Lemesh VM
    Br Vet J; 1983; 139(2):137-46. PubMed ID: 6301618
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody production against BLV-p24 in calves following application of cell extracts from tumorous lymph nodes of cattle with enzootic bovine leukosis.
    Ristau E; Starick E; Burkardt H; Wittmann W
    Acta Virol; 1988 Mar; 32(2):104-8. PubMed ID: 2899956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of natural cytotoxic activity of lymphocytes from cattle and sheep during the progress of bovine leukosis.
    Yamamoto S; Onuma M; Kodama H; Mikami T; Izawa H
    Vet Microbiol; 1984 Apr; 9(2):105-11. PubMed ID: 6328736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of colostral antibody on bovine leukemia virus infection of neonatal calves.
    Van Der Maaten MJ; Miller JM; Schmerr MJ
    Am J Vet Res; 1981 Sep; 42(9):1498-500. PubMed ID: 6275754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specific.
    Thorn RM; Gupta P; Kenyon SJ; Ferrer JF
    Infect Immun; 1981 Oct; 34(1):84-9. PubMed ID: 6271688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An attempt to protect calves against experimental bovine leukosis using allografts.
    Roberts DH; Lucas MH; Wibberley G; Swallow C
    Vet Microbiol; 1985 Apr; 10(3):231-9. PubMed ID: 2988184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine leukemia virus-specific antibodies in French cattle. III. Prevalence of the BLV-gp 51 radioimmunoassay for the detection of BLV-infected animals.
    Levy D; Deshayes L; Parodi AL; Levy JP
    Int J Cancer; 1980 Jan; 25(1):147-52. PubMed ID: 6249762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production of gp 51 of bovine leukosis virus in tumor tissue cells without lysis of cells by cytotoxic antibodies against gp 51].
    Ristau E; Weppe C
    Arch Exp Veterinarmed; 1984 Sep; 38(5):722-8. PubMed ID: 6099108
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudotype particles of vesicular stomatitis virus with surface antigens of bovine leukaemia virus--VSV (BLV) -- as a sensitive probe for detecting antibodies in the sera of spontaneously infected cattle.
    Závada J; Cerný L; Altstein AD; Závadová Z
    Acta Virol; 1978 Mar; 22(2):91-6. PubMed ID: 26209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of bovine leukemia virus release.
    Onuma M; Olson C; Baumgartener LE
    J Natl Cancer Inst; 1975 May; 54(5):1199-202. PubMed ID: 165311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive antibodies to BLV and HTLV in bovine and human hosts with retrovirus infection.
    Maruyama K; Fukushima T; Mochizuki S
    Vet Immunol Immunopathol; 1989 Oct; 22(3):265-73. PubMed ID: 2560858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of bovine leukemia virus infection in Florida.
    Burridge MJ; Puhr DM; Hennemann JM
    J Am Vet Med Assoc; 1981 Oct; 179(7):704-7. PubMed ID: 6281220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by vaccination against bovine leukemia virus infection in sheep.
    Onuma M; Hodatsu T; Yamamoto S; Higashihara M; Masu S; Mikami T; Izawa H
    Am J Vet Res; 1984 Jun; 45(6):1212-5. PubMed ID: 6331233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey for maternal antibodies to bovine leukemia virus (BLV) in calves born to cows infected with BLV.
    Ohshima K; Morimoto N; Kagawa Y; Numakunai S; Hirano T; Kayano H
    Nihon Juigaku Zasshi; 1984 Aug; 46(4):583-6. PubMed ID: 6092762
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and behavior of the precipitating BLV antibodies in sera of leukotic cattle.
    Matthaeus W; Kaaden OR; Frenzel B; Schlotterer E
    Int J Cancer; 1978 Aug; 22(2):166-73. PubMed ID: 81182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.